Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies

The ABCB1 transporter also known as P-glycoprotein (P-gp) is a transmembrane protein belonging to the ATP binding cassette super-family of transporters; it is a xenobiotic efflux pump that limits intracellular drug accumulation by pumping the compounds out of cells. P-gp contributes to a decrease of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of molecular sciences 2020-06, Vol.21 (11), p.4058
Hauptverfasser: Mora Lagares, Liadys, Minovski, Nikola, Caballero Alfonso, Ana Yisel, Benfenati, Emilio, Wellens, Sara, Culot, Maxime, Gosselet, Fabien, Novič, Marjana
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 11
container_start_page 4058
container_title International journal of molecular sciences
container_volume 21
creator Mora Lagares, Liadys
Minovski, Nikola
Caballero Alfonso, Ana Yisel
Benfenati, Emilio
Wellens, Sara
Culot, Maxime
Gosselet, Fabien
Novič, Marjana
description The ABCB1 transporter also known as P-glycoprotein (P-gp) is a transmembrane protein belonging to the ATP binding cassette super-family of transporters; it is a xenobiotic efflux pump that limits intracellular drug accumulation by pumping the compounds out of cells. P-gp contributes to a decrease of toxicity and possesses broad substrate specificity. It is involved in the failure of numerous anticancer and antiviral chemotherapies due to the multidrug resistance (MDR) phenomenon, where it removes the chemotherapeutics out of the targeted cells. Understanding the details of the ligand-P-gp interaction is therefore crucial for the development of drugs that might overcome the MRD phenomenon and for obtaining a more effective prediction of the toxicity of certain compounds. In this work, an in silico modeling was performed using homology modeling and molecular docking methods with the aim of better understanding the ligand-P-gp interactions. Based on different mouse P-gp structural templates from the PDB repository, a 3D model of the human P-gp ( P-gp) was constructed by means of protein homology modeling. The homology model was then used to perform molecular docking calculations on a set of thirteen compounds, including some well-known compounds that interact with P-gp as substrates, inhibitors, or both. The sum of ranking differences (SRD) was employed for the comparison of the different scoring functions used in the docking calculations. A consensus-ranking scheme was employed for the selection of the top-ranked pose for each docked ligand. The docking results showed that a high number of π interactions, mainly π-sigma, π-alkyl, and π-π type of interactions, together with the simultaneous presence of hydrogen bond interactions contribute to the stability of the ligand-protein complex in the binding site. It was also observed that some interacting residues in P-gp are the same when compared to those observed in a co-crystallized ligand (PBDE-100) with mouse P-gp (PDB ID: 4XWK). Our in silico approach is consistent with available experimental results regarding P-gp efflux transport assay; therefore it could be useful in the prediction of the role of new compounds in systemic toxicity.
doi_str_mv 10.3390/ijms21114058
format Article
fullrecord <record><control><sourceid>pubmed_hal_p</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7312539</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>32517082</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-a18505ddeb5dbecac0c1c942bf142fb13b32fb76605368460a7b2ce911307a3c3</originalsourceid><addsrcrecordid>eNpdkctLw0AQxhdRrFZvnmWPFozuI8-L0NZHChEF9Rw2u5tka7Jbskmx_70J1VI9fcPMNz9m-AC4wOiG0gjdqmVtCcbYRV54AE6wS4iDkB8c7tUjcGrtEiFCiRcdg1EvOEAhOQFfsalNZYoNfDZCVkoX0OSwLSWMu5pp-OoU1YabVWNaqTS8ms7mMzyBTAu40FYVZWuh0q2BiSqG5kxpMUDasjFdUfbUSvKuYg28N_xzmLy1nVDSnoGjnFVWnv_oGHw8PrzPYyd5eVrMp4nDXRy2DsOhhzwhZOaJTHLGEcc8ckmW98_lGaYZ7SXwfeRRP3R9xIKMcBlhTFHAKKdjcLflrrqsloJL3TasSleNqlmzSQ1T6d-JVmVamHUaUEw8GvWAyRZQ_luLp0k69FBvDAgN17j3Xm-9vDHWNjLfLWCUDmml-2n19sv923bm33joNxN_kZA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies</title><source>MEDLINE</source><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Mora Lagares, Liadys ; Minovski, Nikola ; Caballero Alfonso, Ana Yisel ; Benfenati, Emilio ; Wellens, Sara ; Culot, Maxime ; Gosselet, Fabien ; Novič, Marjana</creator><creatorcontrib>Mora Lagares, Liadys ; Minovski, Nikola ; Caballero Alfonso, Ana Yisel ; Benfenati, Emilio ; Wellens, Sara ; Culot, Maxime ; Gosselet, Fabien ; Novič, Marjana</creatorcontrib><description>The ABCB1 transporter also known as P-glycoprotein (P-gp) is a transmembrane protein belonging to the ATP binding cassette super-family of transporters; it is a xenobiotic efflux pump that limits intracellular drug accumulation by pumping the compounds out of cells. P-gp contributes to a decrease of toxicity and possesses broad substrate specificity. It is involved in the failure of numerous anticancer and antiviral chemotherapies due to the multidrug resistance (MDR) phenomenon, where it removes the chemotherapeutics out of the targeted cells. Understanding the details of the ligand-P-gp interaction is therefore crucial for the development of drugs that might overcome the MRD phenomenon and for obtaining a more effective prediction of the toxicity of certain compounds. In this work, an in silico modeling was performed using homology modeling and molecular docking methods with the aim of better understanding the ligand-P-gp interactions. Based on different mouse P-gp structural templates from the PDB repository, a 3D model of the human P-gp ( P-gp) was constructed by means of protein homology modeling. The homology model was then used to perform molecular docking calculations on a set of thirteen compounds, including some well-known compounds that interact with P-gp as substrates, inhibitors, or both. The sum of ranking differences (SRD) was employed for the comparison of the different scoring functions used in the docking calculations. A consensus-ranking scheme was employed for the selection of the top-ranked pose for each docked ligand. The docking results showed that a high number of π interactions, mainly π-sigma, π-alkyl, and π-π type of interactions, together with the simultaneous presence of hydrogen bond interactions contribute to the stability of the ligand-protein complex in the binding site. It was also observed that some interacting residues in P-gp are the same when compared to those observed in a co-crystallized ligand (PBDE-100) with mouse P-gp (PDB ID: 4XWK). Our in silico approach is consistent with available experimental results regarding P-gp efflux transport assay; therefore it could be useful in the prediction of the role of new compounds in systemic toxicity.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms21114058</identifier><identifier>PMID: 32517082</identifier><language>eng</language><publisher>Switzerland: MDPI</publisher><subject>Animals ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; ATP Binding Cassette Transporter, Subfamily B, Member 1 - chemistry ; ATP Binding Cassette Transporter, Subfamily B, Member 1 - metabolism ; Binding Sites ; Biochemistry, Molecular Biology ; Density Functional Theory ; Drug Discovery - methods ; Hydrogen Bonding ; Life Sciences ; Ligands ; Molecular Docking Simulation ; Molecular Dynamics Simulation ; Protein Binding ; Protein Conformation ; Reproducibility of Results ; Structural Biology ; Structure-Activity Relationship</subject><ispartof>International journal of molecular sciences, 2020-06, Vol.21 (11), p.4058</ispartof><rights>Attribution - NonCommercial</rights><rights>2020 by the authors. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c418t-a18505ddeb5dbecac0c1c942bf142fb13b32fb76605368460a7b2ce911307a3c3</citedby><cites>FETCH-LOGICAL-c418t-a18505ddeb5dbecac0c1c942bf142fb13b32fb76605368460a7b2ce911307a3c3</cites><orcidid>0000-0002-0481-5026 ; 0000-0002-6205-4675 ; 0000-0003-0039-2246 ; 0000-0001-7452-0867</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312539/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312539/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32517082$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://univ-artois.hal.science/hal-03127238$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Mora Lagares, Liadys</creatorcontrib><creatorcontrib>Minovski, Nikola</creatorcontrib><creatorcontrib>Caballero Alfonso, Ana Yisel</creatorcontrib><creatorcontrib>Benfenati, Emilio</creatorcontrib><creatorcontrib>Wellens, Sara</creatorcontrib><creatorcontrib>Culot, Maxime</creatorcontrib><creatorcontrib>Gosselet, Fabien</creatorcontrib><creatorcontrib>Novič, Marjana</creatorcontrib><title>Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>The ABCB1 transporter also known as P-glycoprotein (P-gp) is a transmembrane protein belonging to the ATP binding cassette super-family of transporters; it is a xenobiotic efflux pump that limits intracellular drug accumulation by pumping the compounds out of cells. P-gp contributes to a decrease of toxicity and possesses broad substrate specificity. It is involved in the failure of numerous anticancer and antiviral chemotherapies due to the multidrug resistance (MDR) phenomenon, where it removes the chemotherapeutics out of the targeted cells. Understanding the details of the ligand-P-gp interaction is therefore crucial for the development of drugs that might overcome the MRD phenomenon and for obtaining a more effective prediction of the toxicity of certain compounds. In this work, an in silico modeling was performed using homology modeling and molecular docking methods with the aim of better understanding the ligand-P-gp interactions. Based on different mouse P-gp structural templates from the PDB repository, a 3D model of the human P-gp ( P-gp) was constructed by means of protein homology modeling. The homology model was then used to perform molecular docking calculations on a set of thirteen compounds, including some well-known compounds that interact with P-gp as substrates, inhibitors, or both. The sum of ranking differences (SRD) was employed for the comparison of the different scoring functions used in the docking calculations. A consensus-ranking scheme was employed for the selection of the top-ranked pose for each docked ligand. The docking results showed that a high number of π interactions, mainly π-sigma, π-alkyl, and π-π type of interactions, together with the simultaneous presence of hydrogen bond interactions contribute to the stability of the ligand-protein complex in the binding site. It was also observed that some interacting residues in P-gp are the same when compared to those observed in a co-crystallized ligand (PBDE-100) with mouse P-gp (PDB ID: 4XWK). Our in silico approach is consistent with available experimental results regarding P-gp efflux transport assay; therefore it could be useful in the prediction of the role of new compounds in systemic toxicity.</description><subject>Animals</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>ATP Binding Cassette Transporter, Subfamily B, Member 1 - chemistry</subject><subject>ATP Binding Cassette Transporter, Subfamily B, Member 1 - metabolism</subject><subject>Binding Sites</subject><subject>Biochemistry, Molecular Biology</subject><subject>Density Functional Theory</subject><subject>Drug Discovery - methods</subject><subject>Hydrogen Bonding</subject><subject>Life Sciences</subject><subject>Ligands</subject><subject>Molecular Docking Simulation</subject><subject>Molecular Dynamics Simulation</subject><subject>Protein Binding</subject><subject>Protein Conformation</subject><subject>Reproducibility of Results</subject><subject>Structural Biology</subject><subject>Structure-Activity Relationship</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkctLw0AQxhdRrFZvnmWPFozuI8-L0NZHChEF9Rw2u5tka7Jbskmx_70J1VI9fcPMNz9m-AC4wOiG0gjdqmVtCcbYRV54AE6wS4iDkB8c7tUjcGrtEiFCiRcdg1EvOEAhOQFfsalNZYoNfDZCVkoX0OSwLSWMu5pp-OoU1YabVWNaqTS8ms7mMzyBTAu40FYVZWuh0q2BiSqG5kxpMUDasjFdUfbUSvKuYg28N_xzmLy1nVDSnoGjnFVWnv_oGHw8PrzPYyd5eVrMp4nDXRy2DsOhhzwhZOaJTHLGEcc8ckmW98_lGaYZ7SXwfeRRP3R9xIKMcBlhTFHAKKdjcLflrrqsloJL3TasSleNqlmzSQ1T6d-JVmVamHUaUEw8GvWAyRZQ_luLp0k69FBvDAgN17j3Xm-9vDHWNjLfLWCUDmml-2n19sv923bm33joNxN_kZA</recordid><startdate>20200605</startdate><enddate>20200605</enddate><creator>Mora Lagares, Liadys</creator><creator>Minovski, Nikola</creator><creator>Caballero Alfonso, Ana Yisel</creator><creator>Benfenati, Emilio</creator><creator>Wellens, Sara</creator><creator>Culot, Maxime</creator><creator>Gosselet, Fabien</creator><creator>Novič, Marjana</creator><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0481-5026</orcidid><orcidid>https://orcid.org/0000-0002-6205-4675</orcidid><orcidid>https://orcid.org/0000-0003-0039-2246</orcidid><orcidid>https://orcid.org/0000-0001-7452-0867</orcidid></search><sort><creationdate>20200605</creationdate><title>Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies</title><author>Mora Lagares, Liadys ; Minovski, Nikola ; Caballero Alfonso, Ana Yisel ; Benfenati, Emilio ; Wellens, Sara ; Culot, Maxime ; Gosselet, Fabien ; Novič, Marjana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-a18505ddeb5dbecac0c1c942bf142fb13b32fb76605368460a7b2ce911307a3c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animals</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>ATP Binding Cassette Transporter, Subfamily B, Member 1 - chemistry</topic><topic>ATP Binding Cassette Transporter, Subfamily B, Member 1 - metabolism</topic><topic>Binding Sites</topic><topic>Biochemistry, Molecular Biology</topic><topic>Density Functional Theory</topic><topic>Drug Discovery - methods</topic><topic>Hydrogen Bonding</topic><topic>Life Sciences</topic><topic>Ligands</topic><topic>Molecular Docking Simulation</topic><topic>Molecular Dynamics Simulation</topic><topic>Protein Binding</topic><topic>Protein Conformation</topic><topic>Reproducibility of Results</topic><topic>Structural Biology</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mora Lagares, Liadys</creatorcontrib><creatorcontrib>Minovski, Nikola</creatorcontrib><creatorcontrib>Caballero Alfonso, Ana Yisel</creatorcontrib><creatorcontrib>Benfenati, Emilio</creatorcontrib><creatorcontrib>Wellens, Sara</creatorcontrib><creatorcontrib>Culot, Maxime</creatorcontrib><creatorcontrib>Gosselet, Fabien</creatorcontrib><creatorcontrib>Novič, Marjana</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mora Lagares, Liadys</au><au>Minovski, Nikola</au><au>Caballero Alfonso, Ana Yisel</au><au>Benfenati, Emilio</au><au>Wellens, Sara</au><au>Culot, Maxime</au><au>Gosselet, Fabien</au><au>Novič, Marjana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2020-06-05</date><risdate>2020</risdate><volume>21</volume><issue>11</issue><spage>4058</spage><pages>4058-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>The ABCB1 transporter also known as P-glycoprotein (P-gp) is a transmembrane protein belonging to the ATP binding cassette super-family of transporters; it is a xenobiotic efflux pump that limits intracellular drug accumulation by pumping the compounds out of cells. P-gp contributes to a decrease of toxicity and possesses broad substrate specificity. It is involved in the failure of numerous anticancer and antiviral chemotherapies due to the multidrug resistance (MDR) phenomenon, where it removes the chemotherapeutics out of the targeted cells. Understanding the details of the ligand-P-gp interaction is therefore crucial for the development of drugs that might overcome the MRD phenomenon and for obtaining a more effective prediction of the toxicity of certain compounds. In this work, an in silico modeling was performed using homology modeling and molecular docking methods with the aim of better understanding the ligand-P-gp interactions. Based on different mouse P-gp structural templates from the PDB repository, a 3D model of the human P-gp ( P-gp) was constructed by means of protein homology modeling. The homology model was then used to perform molecular docking calculations on a set of thirteen compounds, including some well-known compounds that interact with P-gp as substrates, inhibitors, or both. The sum of ranking differences (SRD) was employed for the comparison of the different scoring functions used in the docking calculations. A consensus-ranking scheme was employed for the selection of the top-ranked pose for each docked ligand. The docking results showed that a high number of π interactions, mainly π-sigma, π-alkyl, and π-π type of interactions, together with the simultaneous presence of hydrogen bond interactions contribute to the stability of the ligand-protein complex in the binding site. It was also observed that some interacting residues in P-gp are the same when compared to those observed in a co-crystallized ligand (PBDE-100) with mouse P-gp (PDB ID: 4XWK). Our in silico approach is consistent with available experimental results regarding P-gp efflux transport assay; therefore it could be useful in the prediction of the role of new compounds in systemic toxicity.</abstract><cop>Switzerland</cop><pub>MDPI</pub><pmid>32517082</pmid><doi>10.3390/ijms21114058</doi><orcidid>https://orcid.org/0000-0002-0481-5026</orcidid><orcidid>https://orcid.org/0000-0002-6205-4675</orcidid><orcidid>https://orcid.org/0000-0003-0039-2246</orcidid><orcidid>https://orcid.org/0000-0001-7452-0867</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2020-06, Vol.21 (11), p.4058
issn 1422-0067
1661-6596
1422-0067
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7312539
source MEDLINE; MDPI - Multidisciplinary Digital Publishing Institute; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Animals
Antineoplastic Agents - chemistry
Antineoplastic Agents - pharmacology
ATP Binding Cassette Transporter, Subfamily B, Member 1 - chemistry
ATP Binding Cassette Transporter, Subfamily B, Member 1 - metabolism
Binding Sites
Biochemistry, Molecular Biology
Density Functional Theory
Drug Discovery - methods
Hydrogen Bonding
Life Sciences
Ligands
Molecular Docking Simulation
Molecular Dynamics Simulation
Protein Binding
Protein Conformation
Reproducibility of Results
Structural Biology
Structure-Activity Relationship
title Homology Modeling of the Human P-glycoprotein (ABCB1) and Insights into Ligand Binding through Molecular Docking Studies
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T00%3A48%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Homology%20Modeling%20of%20the%20Human%20P-glycoprotein%20(ABCB1)%20and%20Insights%20into%20Ligand%20Binding%20through%20Molecular%20Docking%20Studies&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Mora%20Lagares,%20Liadys&rft.date=2020-06-05&rft.volume=21&rft.issue=11&rft.spage=4058&rft.pages=4058-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms21114058&rft_dat=%3Cpubmed_hal_p%3E32517082%3C/pubmed_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32517082&rfr_iscdi=true